The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Antitumor efficacy of cisplatin-loaded glycol chitosan nanoparticles in tumor-bearing mice
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
A clearer vision for in vivo imaging
Weissleder, R. (2001) · Nature Biotechnology · doi:10.1038/86684 · Cited by 3,839
Long-Circulating and Target-Specific Nanoparticles: Theory to Practice
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01494-7 · Cited by 3,515
Recent advances on chitosan-based micro- and nanoparticles in drug delivery
Agnihotri, S. A., Mallikarjuna, N. N., & Aminabhavi, T. M. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.08.010 · Cited by 2,586
Novel cisplatin-incorporated polymeric micelles can eradicate solid tumors in mice.
Nishiyama, N., Okazaki, S., Cabral, H., Miyamoto, M., Kato, Y., Sugiyama, Y., Nishio, K., Matsumura, Y., & Kataoka, K. (2003) · PubMed · Cited by 710
Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor
Lee, E. S., Na, K., & Bae, Y. H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.12.018 · Cited by 577
Development of the polymer micelle carrier system for doxorubicin
Nakanishi, T., Fukushima, S., Okamoto, K., Suzuki, M., Matsumura, Y., Yokoyama, M., Okano, T., Sakurai, Y., & Kataoka, K. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00341-8 · Cited by 570
Chitosan-Based Particles as Controlled Drug Delivery Systems
Prabaharan, M., & Mano, J. F. (2004) · Drug Delivery · doi:10.1080/10717540590889781 · Cited by 564
HPMA copolymer–anticancer drug conjugates: design, activity, and mechanism of action
Kopecek, J. (2000) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/s0939-6411(00)00075-8 · Cited by 562
Avgoustakis, K. (2002) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00530-2 · Cited by 503
Uchino, H., Matsumura, Y., Negishi, T., Koizumi, F., Hayashi, T., Honda, T., Nishiyama, N., Kataoka, K., Naito, S., & Kakizoe, T. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602772 · Cited by 430
Targeting angiogenesis with a conjugate of HPMA copolymer and TNP-470
Satchi-Fainaro, R., Puder, M., Davies, J. W., Tran, H. T., Sampson, D. A., Greene, A. K., Corfas, G., & Folkman, J. (2004) · Nature Medicine · doi:10.1038/nm1002 · Cited by 345
Hydrophobically modified glycol chitosan nanoparticles as carriers for paclitaxel
Kim, J.-H., Kim, Y.-S., Kim, S., Park, J. H., Kim, K., Choi, K., Chung, H., Jeong, S. Y., Park, R.-W., Kim, I.-S., et al. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2005.12.013 · Cited by 313
Self-citationHyung Park, J., Kwon, S., Lee, M., Chung, H., Kim, J.-H., Kim, Y.-S., Park, R.-W., Kim, I.-S., Bong Seo, S., Kwon, I. C., et al. (2006) · Biomaterials · doi:10.1016/j.biomaterials.2005.05.028 · Cited by 296
Self-citationKwon, S., Park, J. H., Chung, H., Kwon, I. C., Jeong, S. Y., & Kim, I.-S. (2003) · Langmuir · doi:10.1021/la0350608 · Cited by 269
Self-citationSon, Y. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00231-1 · Cited by 267
Stealth liposomes and tumor targeting: one step further in the quest for the magic bullet.
Gabizón, A. (2001) · PubMed · Cited by 259
SEVERE NEUROTOXICITY, OTOTOXICITY AND NEPHROTOXICITY FOLLOWING HIGH-DOSE CISPLATIN AND AMIFOSTINE
Sastry, J., & Kellie, S. J. (2005) · Pediatric Hematology and Oncology · doi:10.1080/08880010590964381 · Cited by 258
Park, K., Kim, J.-H., Nam, Y. S., Lee, S., Nam, H. Y., Kim, K., Park, J. H., Kim, I.-S., Choi, K., Kim, S. Y., et al. (2007) · Journal of Controlled Release · doi:10.1016/j.jconrel.2007.04.009 · Cited by 257
Self-citationCheon Lee, S., Kim, C., Chan Kwon, I., Chung, H., & Young Jeong, S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00162-7 · Cited by 241
Cisplatin-induced renal toxicity and toxicity-modulating strategies: a review
Pinzani, V., Bressolle, F., Johanne Haug, I., Galtier, M., Blayac, J. P., & Balm�s, P. (1994) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686277 · Cited by 217
Walter, K. A., Tamargo, R. J., Olivi, A., Burger, P. C., & Brem, H. (1995) · Neurosurgery · doi:10.1227/00006123-199512000-00013 · Cited by 206
Park, J. H., Kwon, S., Nam, J.-O., Park, R.-W., Chung, H., Seo, S. B., Kim, I.-S., Kwon, I. C., & Jeong, S. Y. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2003.12.020 · Cited by 190
Self-citationKim, K., Kwon, S., Park, J. H., Chung, H., Jeong, S. Y., Kwon, I. C., & Kim, I.-S. (2005) · Biomacromolecules · doi:10.1021/bm049305m · Cited by 180
Self-citationPark, J. H., Cho, Y. W., Chung, H., Kwon, I. C., & Jeong, S. Y. (2003) · Biomacromolecules · doi:10.1021/bm034094r · Cited by 158
Self-citationOkuda, T., Kawakami, S., Akimoto, N., Niidome, T., Yamashita, F., & Hashida, M. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.09.012 · Cited by 128
小西, 光., Tabata, Y., Kariya, M., Suzuki, A., Mandai, M., Nanbu, K., Takakura, K., & Fujii, S. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00364-x · Cited by 112
Chytil, P., Etrych, T., Koňák, Č., Šírová, M., Mrkvan, T., Říhová, B., & Ulbrich, K. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.028 · Cited by 99
Improved preparation of amyloid‐β peptides using DBU as Nα‐Fmoc deprotection reagent
Tickler, A. K., Barrow, C. J., & Wade, J. D. (2001) · Journal of Peptide Science · doi:10.1002/psc.342 · Cited by 94
Polymeric conjugates of mono- and bi-cyclic αVβ3 binding peptides for tumor targeting
Mitra, A., Coleman, T., Borgman, M. P., Nan, A., Ghandehari, H., & Line, B. R. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.06.014 · Cited by 82
Ning, S., Yu, N. Y., Brown, D., Kanekal, S., & Knox, S. J. (1999) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(98)00134-0 · Cited by 53
Cited by
Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy
Pérez-Herrero, E., & Fernández-Medarde, A. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.03.018 · Cited by 1,875
Injectable and biodegradable hydrogels: gelation, biodegradation and biomedical applications
Li, Y., Rodrigues, J., & Tomás, H. (2012) · Chem. Soc. Rev. · doi:10.1039/c1cs15203c · Cited by 1,445
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging
Parveen, S., Misra, R., & Sahoo, S. K. (2012) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2011.05.016 · Cited by 1,436
Targeted delivery of low molecular drugs using chitosan and its derivatives
Park, J. H., Saravanakumar, G., Kim, K., & Kwon, I. C. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.10.003 · Cited by 821
Self-citationAhmed, T., & Aljaeid, B. (2016) · Drug Design, Development and Therapy · doi:10.2147/dddt.s99651 · Cited by 705
Metadata
- Authors
- Kim, J.-H., Kim, Y.-S., Park, K., Lee, S., Nam, H. Y., Min, K. H., Jo, H. G., Park, J. H., Choi, K., Jeong, S. Y., Park, R.-W., Kim, I.-S., Kim, K., & Kwon, I. C.
- Venue
- Journal of Controlled Release
- Publisher
- Elsevier BV
- Published
- 2008-04
- Volume
- 127
- Issue
- 1
- Pages
- 41-49
- ISSN
- 0168-3659 (ISSN-L)
- OpenAlex
- W2003495186
- Cited by
- 350
- References
- 31
- FWCI
- 12.10
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.